OrganicLeaps by Bayer leads Robigo Bio Series A for engineered crop biologicals
Cambridge, Massachusetts-based Robigo Bio has closed a Series A round led by Leaps by Bayer to bring engineered microbial seed treatments for soybean Sudden Death Syndrome and fusarium wilt to market in 2028 and 2029.